Congenital afibrinogenemia and dysfibrinogenemia can cause juxtatrabecular hemorrhages and bone changes. Further skeletal studies are recommended for patients with clotting disorders.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: